Lurie Cancer Center Completes Dosing of First Patient with LIXTE’s LB-100 in Combination with GSK’s Immunotherapy Dostarlimab --PASADENA, ...

The firm will test additional doses and use its proprietary drug response predictor to gather data that can inform a registrational study.

These drugs, discovered decades ago, continue to save lives today, but more recent research has led to the development of ...

Some New York doctors are working on new ways to treat advanced cancers. Chimeric Antigen Receptor, or CAR, T-cell therapy ...

Pancreatic cancer is fueled by connections to the nervous system. This is reported by scientists from the German Cancer ...

“Platinum chemotherapies remain the standard of care for these cancer types, and I hope that this research provides a basis for the imperative to secure a robust supply chain of these and other ...